510(k) Report

510(k) · Cleared

Cleared

ProBx Software

K173312510(k) TraditionalCleared Mar 2, 2018134-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Harmonus, Inc. · LLZ System, Image Processing, Radiological

Cleared on Mar 2, 2018 as substantially equivalent to K133030 (Invivo Corporation, 2014) after a 134-day review. Its family tree reaches back 7 generations to 1996.

Decided
Mar 2, 2018
Review
134 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K954678 (1996). 25 ancestors in all, the oldest K913475 (1991). No later device cites it as a predicate yet.

  1. Root · 7 generations backK954678 Pro VisionAlgotec Systems, Ltd. · 1996
  2. 6 generations backK980648 Pro VisionAlgotec Systems, Ltd. · 1998
  3. 5 generations backK992654 Plug 'N View 3D, Version 1.0Voxar Limited · 1999
  4. 4 generations backK020546 Fusion 7DMirada Solutions, Ltd. · 2002
  5. 3 generations backK031779 CadstreamConfirma, Inc. · 2003
  6. 2 generations backK041286 Dynacad V1.0Mri Devices Corp. · 2004
  7. 1 generation backK133030 Dynacad/Prostate Interventional (Dynaloc/Prostate)Invivo Corporation · 2014 · Recalled
  8. This deviceK173312 ProBx SoftwareHarmonus, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K954678Pro VisionAlgotec Systems, Ltd.1996—
−6K980648Pro VisionAlgotec Systems, Ltd.1998—
−5K992654Plug 'N View 3D, Version 1.0Voxar Limited1999—
−4K020546Fusion 7DMirada Solutions, Ltd.2002—
−3K031779CadstreamConfirma, Inc.2003—
−2K041286Dynacad V1.0Mri Devices Corp.2004—
−1K133030Dynacad/Prostate Interventional (Dynaloc/Prostate)Invivo Corporation20141
0 (this device)K173312ProBx SoftwareHarmonus, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199120
199420
199520
199620
199820
199910
200010
200130
200210
200320
FIG. 1 — Lineage of K173312, 1996–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133030Dynacad/Prostate Interventional (Dynaloc/Prostate)
Summary page 5
…Image Processing, Radiological, LLZ Classification regulation: 21 CFR 892.2050, Product Code LLZ Predicate Device: DynaCAD/Prostate Interventional, K133030 Device Description: ProBx Software along with ProBx Hardware accessories is used for in-bore Magnetic Resonance Imaging (MRI) gu…
Invivo Corporation20141
†K170250SmartTargetSmarttarget, Ltd.20171

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 7 companies; a new generation was cleared every 2.5 years on median.
  • 6 of the 25 ancestors have a recall of any class.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

ProBx Software is intended for use as follows: • ProBx Software is a computer-based image-guidance accessory intended for use in conjunction with commercially available Magnetic Resonance Imaging (MRI) systems and interventional devices. • ProBx Software helps physicians guide biopsy instrumentation to targets that have been defined by the physician in MRI. The Software provides the clinician with image analysis and display of pre-procedural and…

Read the full statement (128 words)

ProBx Software is intended for use as follows:

• ProBx Software is a computer-based image-guidance accessory intended for use in conjunction with commercially available Magnetic Resonance Imaging (MRI) systems and interventional devices.

• ProBx Software helps physicians guide biopsy instrumentation to targets that have been defined by the physician in MRI. The Software provides the clinician with image analysis and display of pre-procedural and intra-procedural MRI images of tracked accessory hardware and the target organs, along with the projected path to the target. The Software displays an MRI image of the current location of the interventional instrument for positioning confirmation.

• ProBx Software is intended to be used by physicians in a clinical setting for treatment planning and guidance for clinical, interventional, and/or diagnostic procedures of the prostate.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173312: ProBx Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173312

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026